Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries

International Journal of Antimicrobial Agents

Volumn 24, Issue 3, 2004, Pages 268-278

  Meunier, D ^a   Acar, J F ^b   Martel, J L ^a   Kroemer, S ^c   Valle M ^c  

^a Healthy Pigs Production and Experimentation Section   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Global Drug Development Center   (France)

Author keywords

Bovine infection; European survey; Marbofloxacin

Indexed keywords

MARBOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CATTLE; CATTLE DISEASE; CONTROLLED STUDY; DRUG SENSITIVITY; ESCHERICHIA COLI; HISTOPHILUS SOMNI; MANNHEIMIA HAEMOLYTICA; MASTITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; PATHOGENICITY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS UBERIS; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; BACTERIUM; DRUG EFFECT; ENTERITIS; EUROPE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS;

ESCHERICHIA COLI; HAEMOPHILUS SOMNUS; PASTEURELLA MULTOCIDA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS UBERIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CATTLE; CATTLE DISEASES; DRUG RESISTANCE, BACTERIAL; ENTERITIS; ESCHERICHIA COLI; EUROPE; FLUOROQUINOLONES; HAEMOPHILUS SOMNUS; MANNHEIMIA HAEMOLYTICA; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; PASTEURELLA MULTOCIDA; QUINOLONES; RESPIRATORY TRACT INFECTIONS; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 4344626923     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.12.011     Document Type: Article

References (22)

1. Bager F. DANMAP: monitoring antimicrobial resistance in Denmark. Int. J. Antimicrob. Agents. 14:2000;271-274
2. Martel J.-L., Tardy F., Brisabois A., Lailler R., Coudert M., Chaslus-Dancla E. The French antibiotic resistance monitoring programs. Int. J. Antimicrob. Agents. 14:2000;275-283
3. Moreno M-A, Dominguez L, Teshager T, Herrero I-A, Porrero M-C, the VAV Network. Antibiotic resistance monitoring: the Spanish programme. Int J Antimicrob Agents 2000;14:285-90.
4. Wray C., Gnanou J.-C. Antibiotic resistance monitoring in bacteria of animal origin: analysis of national monitoring programmes. Int. J. Antimicrob. Agents. 14:2000;291-294
5. Caprioli A., Busani L., Martel J.-L., Helmuth R. Monitoring of antibiotic resistance in bacteria of animal origin: epidemiological and microbiological methodologies. Int. J. Antimicrob. Agents. 14:2000;295-301
6. Spreng M., Deleforge J., Thomas V., Boisramé B., Drugeon H. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. J. Vet. Pharmacol. Ther. 18:1995;284-289
7. Drugeon H. La pharmacodynamie des antibiotiques. In: Congrès de la Société Française de Buiatrie, Paris, France; 1994. p. 3-16.
8. Dudley N. Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. Am. J. Med. 6A:1991;45S-50S
9. Pellet T, Tonnelier A, Gicquel M, Angenard G, Sanders P, Laurentie M. Pharmacodynamies de la marbofloxacines sur différentes populations d'Escherichia coli et de Salmonelles de différentes sensibilités. In: 2eme colloque Francophone de Bactériologie Vétérinaire, Ploufragan, France; 2002. p. 103.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals approved standard M31-A1. Villanova, PA, USA: NCCLS; 1999.
11. National Committee for Clinical Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents approved standard M37-A1. Villanova, PA, USA: NCCLS; 1999.
12. Everett M.J., Jin Y.F., Ricci V., Piddock L.J.V. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:1996;2380-2386
13. Yoshida H., Bogaki M., Nakamura M., Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1990;1271-1272
14. Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:1996;879-885
15. Thomas V, Delforge J, Boisramé B. Pharmacokinetics of marfloxacin in pre-ruminant and ruminant cattle. In: Proceedings of the 6th International Congress of European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland; 1994. p. 60.
16. Banting A, Scheider M, Thomas E. Comparaison des concentrations de marbofloxacine et de danofloxacine dans le plasma, les sécrétions nasales et bronchiques chez le jeune bovin. In: Congrès de la Société Française de Buiatrie, Paris, France; 1997. p. 41-2.
17. Eyett-Burton C. Marbofloxacin: an advanced fluoroquinolone for use in beef and Dairy Cattle. Cattle Pract. l5:1997;289-290
18. Wiuff C., Lykkefeldt J., Aarestrup F.M., Svendsen O. Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. J. Vet. Pharmacol. Ther. 25:2002;335-342
19. Heisig P. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J. Antimicrob. Chemother. 32:1993;367-377
20. Baucheron S., Imberechts H., Chaslus-Dancla E., Cloeckaert A. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT 204. Microb. Drug Resist. 8:2002;281-288
21. Giraud E., Brisabois A., Martel J.L., Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43:1999;2131-2137
22. Kehrenberg C., Schulze-Tanzil G., Martel J.L., Chaslus-Dancla E., Schwarz S. Antimicrobial resistance in Pasteurella and Mannheimia: epidemiology and genetic basis. Vet. Res. 32:2001;323-339